This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
SERZONE TABLETS 250MG — Description, Dosage, Side Effects | PillsCard
OTC
SERZONE TABLETS 250MG
錠劑
INN: NEFAZODONE
Data updated: 2026-04-11
Available in:
🇬🇧
Form
錠劑
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY (TW)
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ATC Code
N06AX06
Source
TFDA
C
N06AX06(WHO)
AU:S4(Prescription only)BR:Class C1(Other controlled substances)US:℞-onlyIn general: ℞ (Prescription only)
1-(3-[4-(3-chlorophenyl)piperazin-1-yl]propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one
83366-66-9Y82752-99-6 (hydrochloride)
4449
7247
DB01149Y
4294Y
59H4FCV1TF
D08257Y
CHEBI:7494Y
ChEMBL623Y
DTXSID2023357
Interactive image
Clc4cccc(N3CCN(CCCN1/N=C(\N(C1=O)CCOc2ccccc2)CC)CC3)c4
InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3YKey:VRBKIVRKKCLPHA-UHFFFAOYSA-NY
Nefazodone, sold formerly under the brand namesSerzone,Dutonin, andNefadaramong others, is anatypical antidepressantmedication which is used in the treatment ofdepressionand for other uses.Nefazodone was withdrawn in most countries by 2004(due to liver toxicity). On December 2021, it was published that despite shortage it is still available in the United States.As of February 2026 it is available in the United States in generic form. The medication is takenby mouth.
Side effectsof nefazodone includedry mouth,sleepiness,nausea,dizziness,blurred vision,weakness,lightheadedness,confusion, andpostural low blood pressure, among others.Rarely, nefazodone can cause seriousliver damage, with an incidence of death orliver transplantationof about 1 in every 250,000 to 300,000 patient years.Nefazodone is aphenylpiperazinecompoundand is related totrazodone. It has been described as aserotonin antagonist and reuptake inhibitor(SARI) due to its combined actions as apotentantagonistof theserotonin5-HT2Aand5-HT2Creceptorsand weakserotonin–norepinephrine–dopamine reuptake inhibitor(SNDRI).
Nefazodone was introduced for medical use in 1994.Generic versionswere introduced in 2003.Serious liver toxicity was first reported with nefazodone in 1998, and it was withdrawn from most markets by 2004.However, as of 2023, it continues to be available in the United States in generic from one manufacturer,Teva Pharmaceuticals[failed verification]and is manufactured in Israel.
⚠️ Warnings
• Caution should be exercised in patients with seizures, heart attack, chest pain, stroke, or other heart disease, liver disease, stomach bleeding, suicidal tendencies, who are taking other medications, any allergy, during pregnancy and breastfeeding.
• It may cause drowsiness, dizziness, blurred vision, or lightheadedness, do not drive a car or operate machinery while taking this medication.
• Avoid alcohol consumption.
• Monitor liver function, kidney function, and complete blood cell counts regularly while taking this medication.
• Patient may develop with increased risk of suicidal thoughts; watch them carefully.